Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review. Issue 8 (21st August 2021)

• Record Type: Journal Article
• Authors: Gatto, Lidia; Franceschi, Enrico; Tosoni, Alicia; Di Nunno, Vincenzo; Maggio, Ilaria; Tonon, Caterina; Lodi, Raffaele; Agati, Raffaele; Bartolini, Stefania; Brandes, Alba Ariela
• Is Part Of: Clinical case reports. Volume 9:Issue 8(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-08-21
• Subjects: antiangiogenic treatment -- glioblastoma multiforme -- pseudoresponse -- RANO criteria -- regorafenib -- tyrosine kinase inhibitors; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.4604
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images. Abstract : Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images.